Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan BorénDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital , Gothenburg, SwedenM. John ChapmanEndocrinology-Metabolism Division, Pitié-Salpêtrière University Hospital, Sorbonne University , Paris, FranceRonald M. KraussChris J. PackardInstitute of Cardiovascular and Medical Sciences, University of Glasgow , Glasgow, UKJacob Fog BentzonCentro Nacional de Investigaciones Cardiovasculares Carlos III , Madrid, SpainChristoph J. BinderDepartment of Laboratory Medicine, Medical University of Vienna, Research Center for Molecular Medicine of the Austrian Academy of Sciences , Vienna, AustriaMat J.A.P. DaemenDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences , Amsterdam, The NetherlandsLinda L. DemerDepartment of Bioengineering, University of California , Los Angeles, Los Angeles, CA, USARobert A. HegeleDepartment of Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University , London, Ontario, CanadaStephen J. NichollsMonash Cardiovascular Research Centre, Monash University , Melbourne, AustraliaBørge G. NordestgaardDepartment of Clinical Biochemistry, The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen , DenmarkGerald F. WattsDepartment of Cardiology, Lipid Disorders Clinic, Royal Perth Hospital , Perth, AustraliaÉric BruckertINSERM UMRS1166, Department of Endocrinology-Metabolism, ICAN - Institute of CardioMetabolism and Nutrition, AP-HP, Hopital de la Pitie , Paris, FranceSergio FazioDepartments of Medicine, Physiology and Pharmacology, Knight Cardiovascular Institute, Center of Preventive Cardiology, Oregon Health & Science University , Portland, OR, USABrian A. FerenceCentre for Naturally Randomized Trials, University of Cambridge , Cambridge, UKIan GrahamTrinity College Dublin , Dublin, IrelandJay D. HortonDepartment of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX, USAUlf LandmesserBerlin Institute of Health (BIH) , Berlin, GermanyUlrich LaufsKlinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig , Liebigstraße 20, Leipzig, GermanyL. MasanaResearch Unit of Lipids and Atherosclerosis, IISPV, CIBERDEM, University Rovira i Virgili , C. Sant Llorenç 21, Reus 43201, SpainGerard PasterkampLaboratory of Clinical Chemistry, University Medical Center Utrecht , Utrecht, The NetherlandsFrederick J. RaalCarbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand , Johannesburg, South AfricaKausik K. RayDepartment of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College London , London, UKHeribert SchunkertDZHK (German Centre for Cardiovascular Research) , Partner Site Munich Heart Alliance, Munich, GermanyMarja‐Riitta TaskinenResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki , Helsinki, FinlandBart van de SluisDepartment of Pediatrics, University of Groningen, University Medical Center Groningen , Groningen, The NetherlandsOlov WiklundDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital , Gothenburg, SwedenLâle TokgözoğluDepartment of Cardiology, Hacettepe University Faculty of Medicine , Ankara, TurkeyAlberico L. CatapanoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano , and IRCCS MultiMedica, Milan, ItalyHenry N. GinsbergDepartment of Medicine, Irving Institute for Clinical and Translational Research , Columbia University, New York, NY, USA
2020en
ABI
Аннотация
Abstract
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0